Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials. - Mayo T; Silverberg JI; Armstrong A; Guttman-Yassky E; Blauvelt A; Esdaile B; Kabashima K; Gooderham M; Kircik L; Schneider S; Bennike N; von Eyben R; et al. (American journal of clinical dermatology, 2026)